Evidence map›Paper›PMID 32868913›Full record

ArticleNature biotechnology2021

Single-cell metabolic profiling of human cytotoxic T cells.

Felix J Hartmann, Dunja Mrdjen, Erin McCaffrey, David R Glass, Noah F Greenwald, Anusha Bharadwaj, Zumana Khair, Sanne G S Verberk, Alex Baranski, Reema Baskar and 5 more

Open access · greenAbstract read
In one paragraph

Article in Nature biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 203 papers.

0numbers the graph read from it
0cells of the map it votes in
203citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

203 citing papers in PubMed, 314 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sepsis and the immunometabolic inflammatory response.npj metabolic health and disease · 2026
    Review
  18. Review
  19. Review
  20. Review

143 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Felix J HartmannDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-4174-2276
Dunja MrdjenDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Erin McCaffreyDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
David R GlassDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Noah F GreenwaldDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.ORCID http://orcid.org/0000-0002-7836-4379
Anusha BharadwajDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Zumana KhairDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Sanne G S VerberkDepartment of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Alex BaranskiDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Reema BaskarDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
William GrafDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
David Van ValenDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Jan Van den BosscheDepartment of Molecular Cell Biology and Immunology, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.ORCID http://orcid.org/0000-0002-7852-2891
Michael AngeloDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA.
Sean C BendallDepartment of Pathology, School of Medicine, Stanford University, Palo Alto, CA, USA. bendall@stanford.edu.ORCID http://orcid.org/0000-0003-1341-2453
Stanford University · USPalo Alto University · USAmsterdam University Medical Centers · NLCalifornia Institute of Technology · US

Funding

MOLECULAR &CELLULAR IMMUNOBIOLOGYT32AI007290 · NIAID · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Olivia M Martinez · 1985 to 2026
$27.0M
Stanford Cancer Immune Monitoring and Analysis Center (CIMAC)U24CA224309 · NCI · STANFORD UNIVERSITY · PI Sean Curtis Bendall, Holden T. Maecker · 2017 to 2026
$19.9M
MIRIAD - Multiplexed Imaging of Resilience In Alzheimers DiseaseR01AG057915 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$4.5M
The Phenotypic Landscape of Cognitive Decline as Revealed by Next-Generation Multiplexed Ion Beam ImagingR01AG056287 · NIA · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2017 to 2021
$2.6M
Origins of human blood lineages in regenerative medicineDP2EB024246 · NIBIB · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2016 to 2016
$2.4M
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's DiseaseR01AG068279 · NIA · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2020 to 2024
$1.9M
A robust platform for multiplexed, subcellular proteomic imaging in human tissueUH3CA246633 · NCI · STANFORD UNIVERSITY · PI ANGELO, ROBERT MICHAEL, BENDALL, SEAN CURTIS · 2019 to 2021
$1.8M
A single-cell platform to discover and study regulators of human developmentR00GM104148 · NIGMS · STANFORD UNIVERSITY · PI BENDALL, SEAN CURTIS · 2014 to 2016
$747k
Damon Runyon Cancer Research Foundation DRG-2017-09NCI NIH HHS U24 CA224309NCI NIH HHS UH3 CA246633NIAID NIH HHS T32 AI007290NIA NIH HHS R01 AG056287NIA NIH HHS R01 AG057915NIA NIH HHS R01 AG068279NIBIB NIH HHS DP2 EB024246NIGMS NIH HHS R00 GM104148
6 · The paper itself

Abstract

Cellular metabolism regulates immune cell activation, differentiation and effector functions, but current metabolic approaches lack single-cell resolution and simultaneous characterization of cellular phenotype. In this study, we developed an approach to characterize the metabolic regulome of single cells together with their phenotypic identity. The method, termed single-cell metabolic regulome profiling (scMEP), quantifies proteins that regulate metabolic pathway activity using high-dimensional antibody-based technologies. We employed mass cytometry (cytometry by time of flight, CyTOF) to benchmark scMEP against bulk metabolic assays by reconstructing the metabolic remodeling of in vitro-activated naive and memory CD8

Indexed as

MetabolomeSingle-Cell AnalysisColorectal NeoplasmsHumansLymphocyte ActivationLymphocyte SubsetsMetabolic Flux AnalysisT-Lymphocytes, Cytotoxic

Identifiers

PMID32868913
PMCPMC7878201
OpenAlexW3081828282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.